Literature DB >> 21999586

The neuropsychological profile of infantile Duchenne muscular dystrophy.

Giovanni Mento1, Vincenza Tarantino, Patrizia S Bisiacchi.   

Abstract

It has been shown that children with Duchenne muscular dystrophy (DMD) exhibit specific cognitive deficits. However, the neuropsychological profile has not yet been fully characterized. In order to control for the contribution of motor impairments as a confounding variable that is usually present when assessing children with muscular pathologies, we compared children with DMD to a group of children with an autoimmune pathology that does not entail either brain or cognitive dysfunction but does imply motor impairment: juvenile rheumatoid arthritis (JRA). An extensive neuropsychological evaluation was administered, including intelligence, perception, language, memory and learning, attention, executive function, praxis and reasoning. As the main result, in children with DMD we found significantly lower performances in verbal IQ, verbal short-term memory and phonological abilities, as well as in praxis and executive functioning domains. A wide range of cognitive domains, including verbal abilities, executive functioning, and praxis, must be taken into account when assessing neuropsychological functioning in children with DMD. In particular, subtle executive function impairment could be considered as a subclinical marker of cognitive impairment in developmental disorders.

Entities:  

Mesh:

Year:  2011        PMID: 21999586     DOI: 10.1080/13854046.2011.617782

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  8 in total

1.  The dystrophin gene and cognitive function in the general population.

Authors:  Dina Vojinovic; Hieab H H Adams; Sven J van der Lee; Carla A Ibrahim-Verbaas; Rutger Brouwer; Mirjam C G N van den Hout; Edwin Oole; Jeroen van Rooij; Andre Uitterlinden; Albert Hofman; Wilfred F J van IJcken; Annemieke Aartsma-Rus; GertJan B van Ommen; M Arfan Ikram; Cornelia M van Duijn; Najaf Amin
Journal:  Eur J Hum Genet       Date:  2014-09-17       Impact factor: 4.246

Review 2.  Dystrophin induced cognitive impairment: mechanisms, models and therapeutic strategies.

Authors:  Akshay Anand; Rahul Tyagi; Manju Mohanty; Manoj Goyal; K Ranil D De Silva; Nalaka Wijekoon
Journal:  Ann Neurosci       Date:  2015-04

3.  Aberrant location of inhibitory synaptic marker proteins in the hippocampus of dystrophin-deficient mice: implications for cognitive impairment in duchenne muscular dystrophy.

Authors:  Elżbieta Krasowska; Krzysztof Zabłocki; Dariusz C Górecki; Jerome D Swinny
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

4.  Working Memory Alterations Plays an Essential Role in Developing Global Neuropsychological Impairment in Duchenne Muscular Dystrophy.

Authors:  Rahul Tyagi; Harshita Arvind; Manoj Goyal; Akshay Anand; Manju Mohanty
Journal:  Front Psychol       Date:  2021-01-15

5.  The neurocognitive profile of adults with Becker muscular dystrophy in the Netherlands.

Authors:  Zaıda Koeks; Danique M J Hellebrekers; Nienke M van de Velde; Iris Alleman; Pietro Spitali; Hermine A van Duyvenvoorde; Jan J G M Verschuuren; Jos G M Hendriksen; Erik H Niks
Journal:  J Neuromuscul Dis       Date:  2022

6.  Nonmechanical Roles of Dystrophin and Associated Proteins in Exercise, Neuromuscular Junctions, and Brains.

Authors:  Bailey Nichols; Shin'ichi Takeda; Toshifumi Yokota
Journal:  Brain Sci       Date:  2015-07-29

7.  Computer task performance by subjects with Duchenne muscular dystrophy.

Authors:  Silvia Regina Pinheiro Malheiros; Talita Dias da Silva; Francis Meire Favero; Luiz Carlos de Abreu; Felipe Fregni; Denise Cardoso Ribeiro; Carlos Bandeira de Mello Monteiro
Journal:  Neuropsychiatr Dis Treat       Date:  2015-12-30       Impact factor: 2.570

8.  Improvements in motor tasks through the use of smartphone technology for individuals with Duchenne muscular dystrophy.

Authors:  Camila Miliani Capelini; Talita Dias da Silva; James Tonks; Suzanna Watson; Mayra Priscila Boscolo Alvarez; Lilian Del Ciello de Menezes; Francis Meire Favero; Fátima Aparecida Caromano; Thais Massetti; Carlos Bandeira de Mello Monteiro
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-18       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.